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Population linkage disequilibrium occurs as a consequence of mutation, selection, genetic drift, and population
substructure produced by admixture of genetically distinct ethnic populations. African American and Hispanic
ethnic groups have a history of significant gene flow among parent groups, which can be of value in affecting
genome scans for disease-gene discovery in the case-control and transmission/disequilibrium test designs. Disease-
gene discovery using mapping by admixture linkage disequilibrium (MALD) requires a map of polymorphic markers
that differentiate between the founding populations, along with differences in disease-gene allele frequencies. We
describe markers appropriate for MALDmapping by assessing allele frequencies of 744 short tandem repeats (STRs)
in African Americans, Hispanics, European Americans, and Asians, by choosing STR markers that have large
differences in composite d, log-likelihood ratios, and/or I*(2) for MALD. Additional markers can be added to this
MALD map by utilization of the rapidly growing single-nucleotide–polymorphism databases and the literature, to
achieve a 3–10-cM scanning scale. The map will be useful for studies of diseases, including prostate and breast
cancer, diabetes, hypertension, and end-stage renal disease, that have large differences in incidence between the
founding populations of either Hispanics or African Americans.
Introduction
The analysis of complex human diseases requires novel
genetic strategies and approaches as we enter the known
genomic sequence era. Approaches that involve the use
of traditional family linkage analysis have yielded the
locations of many genes, especially those that are highly
penetrant and encode simple Mendelian disease phe-
notypes. More recently, use of sib-pair analysis, the
transmission/disequilibrium test (TDT), and homozy-
gosity mapping have made the identification of the genes
involved in complex diseases more tractable (Risch and
Merikangas 1996; Risch 2000). Whole-genome scans
have identified genetic regions and genes involved in
many diseases, including type I diabetes, asthma, pros-
tate cancer, and others (e.g., Smith et al. 1996; Mein et
al. 1998; Arngrimsson et al. 1999; The Tourette Syn-
drome Association International Consortium for Ge-
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netics 1999; Bellamy et al. 2000; Walder et al. 2000;
Wiggs et al. 2000). Although these family-based ap-
proaches are powerful and make possible the identifi-
cation of genes involved in many complex diseases, some
diseases in which environmental and viral factors are
important components may be best addressed by ap-
proaches that center around a case-control and TDT
design.
The detection of polymorphic genes that influence
quantitative traits, disease states, and other characters
is the goal of population genetic association studies, but
it depends upon the persistence of measurable linkage
disequilibrium (i.e., haplotype allele association) be-
tween markers and undiscovered loci. In white popu-
lations, the extent and usefulness of linkage disequilib-
rium is generally limited to regions smaller than ∼100
kb, because of recent population history (Bodmer 1986;
Laan and Pa¨a¨bo 1997; Huttley et al. 1999; Reich et al.
2001). The power of this approach depends upon how
far linkage disequilibrium extends over a chromosomal
interval which, in turn, determines the spacing and num-
ber of markers required for a genome scan.
One promising approach is mapping by admixture
linkage disequilibrium (MALD), where the samples are
collected from an admixed population in patient cohorts
(Briscoe et al. 1994; Stephens et al. 1994; McKeigue
1997, 1998; Kaplan et al. 1998; Zheng and Elston
1999). These theoretical treatments and simulations
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Figure 1 dc values for the loci examined across the human genome, in comparisons between European Americans and African Americans
(shaded triangles) and between European Americans and Hispanics (white circles). dc values are shown on the Y-axis, and chromosome position
(in centimorgans) is shown on the X-axis.
point out that recent admixture generates linkage dis-
equilibrium that can extend for many centimorgans and
can persist for as many as 20 generations. We have
recently detected admixture linkage disequilibrium
(ALD) across tens of centimorgans around the FY
(Duffy) gene in African Americans (Lautenberger et al.
2000).
African Americans and Hispanics seem ideal for
MALD-based association ascertainment. Studies have
shown that African Americans represent an admixed
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Figure 2 Relationship between differences seen at individual
markers in dc and LLAR (A) and STR I*(2) (B) in African Americans,
along with African American versus Hispanic dc values (C).
population with significant genetic contributions from
both African and European ancestors (Chakraborty and
Weiss 1988; Chakraborty et al. 1991). Recent estimates
of the proportion of European genes in African Amer-
ican populations range from 6.8% for Sapelo Island in
Georgia to 26% for Chicago (Long 1991; Chakraborty
et al. 1992; Parra et al. 1998; Destro-Bisol et al. 1999).
Hispanics—a complex U.S. ethnic group that includes
Puerto Ricans, Cubans, Mexican Americans, and Span-
ish Americans—also constitute an admixed population
of primarily European, 18%–31% Native American,
and 3%–31% African origins (Hanis et al. 1991; Long
et al. 1991), which is promising for MALD analysis.
Earlier studies of RFLPs suggested that establishing a
collection of differentiating markers would be difficult to
achieve with single-nucleotide polymorphisms (SNPs),
where at most only 20% of 257 markers had large
enough differences to be informative forMALDmapping
(Dean et al. 1994), whereas subsequent work on short
tandem repeat polymorphisms (STRs) suggested that
about half had large differences (Bowcock et al. 1994).
Current efforts of the SNP consortium (Altshuler et al.
2000) are likely to bring these biallelic markers to the
forefront for MALDmapping in a case-control and TDT
setting. However, the more-polymorphic STRs provide
higher information content for TDT and case-control ap-
proaches, and, given the current state of genotyping tech-
nology, an STR-based MALD map provides a valuable
gene-mapping resource.
In the present study, we sought to identify markers
appropriate for MALD analysis, by genotyping of Af-
rican Americans, Europeans, Hispanics, and Asians, us-
ing 421 STR loci and supplementing the data set with
data from 323 markers from an asthma genome scan
(Collaborative Study on the Genetics of Asthma 1997).
These data were used to estimate allele frequencies and
the usefulness of the loci for MALD mapping. Since
MALD assessment provides remarkable potential for
the discovery of novel genes involved in common dis-
eases, the comprehensive set of markers with large dif-
ferences between the founding populations for African
Americans and Hispanics provides a foundation for fu-
ture MALD gene localization studies.
Subjects and Methods
Patient DNAs were obtained from collections of human
DNAs at the Laboratory of Genomic Diversity and in-
cluded 45 African Americans, 45 Europeans, 45 His-
panics, and 40 Asians (Dean et al. 1994; Smith et al.
1997; O’Brien 2000; O’Brien et al. 2000). Early in the
study, a different set of patients was used with fewer
individuals (37 African Americans, 25 European Amer-
icans, 21 Hispanics, and 21 Asians), with the African
American samples containing 18 parent/offspring pairs.
DNAs from lymphoblastoid or fibroblast cell lines were
extracted using methods we have published elsewhere
(Dean et al. 1994). Some of the allele-frequency data
have been reported elsewhere as part of an HIV-1/AIDS
candidate gene analysis (Shin et al. 2000) or an asthma
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Figure 3 Variograms of marker dc in African Americans. For each point, the X and Y coordinates represent the map distance between
markers j and k on chromosome i (map location of j 1 map location of k) and half the squared difference of dc between the markers, respectively
(Diggle et al. 1994). All possible pairs of markers !50 cM apart were examined, and those at intervals of 10 cM are shown. One observation
was off the scale, with a distance of 9 cM and a difference of .25. The line is the estimated kernel smoothing function.
genetics genome scan (Collaborative Study on the Ge-
netics of Asthma 1997).
STR locus primers were obtained from a variety of
sources, including (1) commercial STR panels that were
in development (Applied Biosystems), (2) the Applied
Biosystems X chromosome STR kit, (3) ongoing HIV-
1/AIDS projects (O’Brien et al. 2000; Shin et al. 2000),
(4) work around the FY gene (Lautenberger et al. 2000),
and (5) experiments designed to fill gaps in the MALD
map with additional STR loci. Amplification was per-
formed with Perkin-Elmer 9600 thermal cyclers. Loci
were amplified with AmpliTaq DNA polymerase under
the following conditions: 2 min at 95C; 10 cycles of
30 s at 94C, 15 s at 55C, and 15 s at 72C; 20 cycles
with a lowered (89C) denaturation temperature, fol-
lowed by a 72C final extension for 10 min. In addition,
a Taq gold (PE Biosystems) touchdown protocol was
also used later in the project; this protocol consisted of
10 min at 95C; 10 cycles of 30 s at 94C, 30 s at 65C,
and 30 s at 72C; 20 cycles of the same conditions but
dropping the annealing temperature by 0.5C, to 55C;
15 cycles of annealing at 55C; and a 72C final exten-
sion for 10min. Loci that yielded banding patterns char-
acteristic of A addition were tried again, using a 90-
min final extension, no final extension, and/or by
redesigning the unlabeled reverse primer to add a gua-
nine or to finish with the sequence of GTTT (G/A/C)
at the 5′ end (Brownstein et al. 1996; Magnuson et al.
1996). Primer sequences and allele size ranges for the
primers we designed are available at the Laboratory of
Genomic Diversity Web site. Fluorescently labeled PCR
products (FAM, HEX, TET, and NED) were separated
on Applied Biosystems 373 and 377 sequencers. Gels
were analyzed with Genescan collection and analysis
software, and genotypes were called using Genotyper
software (Applied Biosystems). Alleles were binned us-
ing linear regression, visual examination, and Geno-
typer software. Data were analyzed using the Statistical
Analysis System (SAS) (SAS Institute, Inc.). Estimates of
composite d (dc) and log-likelihood allelic ratio (LLAR)
values (Shriver et al. 1997; Stephens et al. 1999) were
computed by SAS. The dc value is defined as the sum of
the absolute value of all n allelic frequency (fi) differ-
ences divided by 2:
n1
d p # Ff  f F ,c iA iB2 ip1
where fiA and fiB are the frequencies of the ith allele
in the two groups, A and B, being compared at a locus.
The LLAR statistic was calculated over all n alleles as
n n1 f 1 fiA iBLLARp f log  f log . iA iB2 f 2 fip1 ip1iB iA
A program written in Pascal was used to calculate
the MALD-TDT (transmission/disequilibrium test) al-
lele-collapsing statistic, I*(2) (Kaplan et al. 1998). Re-
gression analysis of these comparison measures were
first examined as linear models, and then curvilinear
terms were added to better fit the residuals. Autocor-
relation of dc values for the comparison of European
Americans versus both African Americans and Hispan-
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Figure 4 Cumulative frequency distributions of differences be-
tween African Americans, Asians, Hispanics, and EuropeanAmericans
are shown as dc (A), LLAR (B), and optimized STR allele-collapsing
statistic I*(2) (C) (Kaplan et al. 1998).
ics was examined using longitudinal data analysis tech-
niques (Diggle et al. 1994).
Results
Estimated allele frequencies from the 744 STR loci ex-
amined are available at the Laboratory of Genomic Di-
versity Web site. Those allele frequency estimates were
used to determine differences between the four racial/
ethnic groups. Comparisons of African Americans versus
Asians, African Americans versus European Americans,
African Americans versus Hispanics, Asians versus Eu-
ropean Americans, Asians versus Hispanics, and His-
panics versus European Americans were calculated as
(1) dc, one-half the sum of the absolute value of the allele
frequency differences (Shriver et al. 1997; Stephens et
al. 1999; Lautenberger et al. 2000) and (2) the LLAR
estimate of the discrimination power of each locus de-
rived from some of our previous work (Shriver et al.
1997). The comparisons of African Americans versus
European Americans and of European Americans versus
Hispanics were evaluated as the optimal I*(2) (Kaplan
et al. 1998). Values of dc for the African American versus
European American and the European American versus
Hispanic comparisons are plotted by chromosome po-
sition in figure 1.
A comparison of the behavior of the three MALD sta-
tistics—dc, LLAR, and I*(2)—shows a high level of cor-
relation. For example, in the comparison of 724 loci be-
tween African Americans and European Americans, the
correlation coefficient of LLAR versus dc was .88, with
(fig. 2a). Similar results were obtained5.98XYp 0.12 # e
from the regression of I*(2) versus dc in the same ethnic
group comparison ( ; ; fig.2 7.38Xr p .81 Yp 0.044 # e
2b). Some of the strengths and limitations of these dif-
ferent MALD statistics have been discussed elsewhere
(Shriver et al. 1997; Kaplan et al. 1998; Stephens et al.
1999).
The distribution of dc was examined by chromosome
and as a function of distance. No depression or elevation
of all six dc comparisons was seen by chromosome in
an analysis of variance (results not shown). An auto-
correlation analysis of markers spaced at 50 cM
showed no evidence of closely spaced markers having
similar dc values in either admixed population in var-
iograms. A representative comparison for African
American versus European American differences in dc
of marker pairs10 cM apart is shown in figure 3. The
lack of upward trend in the kernel smoothing line,
which is flat in both populations out to 50 cM (not
shown), indicates that the dc values of closely spaced
marker pairs are no more similar than those of distantly
spaced ones. The sample autocorrelation functions es-
timated with intrapair distances categorized into 1-cM-
wide bins also displayed no evidence of positive auto-
correlation in either population (analysis not shown).
The distribution of allelic differences conforms to our
expectations, which are based upon the natural history
of admixed Hispanics and African Americans (both in-
cluding gene flow from Europeans) and nonadmixed
Asian and European groups (fig. 4). Thus, the greatest
difference is seen in the comparison between Asians and
African Americans (who share little recent admixture),
whereas the smallest differences occur between Hispan-
ics and European Americans. For populations where
MALD analysis would be feasible, appreciable diver-
Table 1
STR Markers Examined, Map Locations, dc, and MALD Map
Status of Markers for European American versus African
American and European American versus Hispanic
Comparisons
CHROMOSOME
AND LOCUS
MAP
LOCATION
(cM)
dc FOR EUROPEAN AMERICAN
VERSUS
African American Hispanic
Chromosome 1:
D1S468a 4.2 .340 .330
D1S1612 16.2 .184 .193
D1S244a 20.6 .331 .269
D1S1597 29.9 .189 .048
D1S228 29.9 .209 .231
D1S3669 37.1 .281 .135
D1S199 45.3 .286 .248
D1S552 45.3 .283 .040
D1S1622b 56.7 .508 .164
D1S255c 65.5 .275 .310
D1S2130 72.6 .132 .095
D1S2134c 75.7 .249 .267
D1S197 76.3 .257 .143
D1S220 87.3 .254 .156
D1S1669 89.8 .222 .165
D1S209a 93.9 .381 .290
D1S1665 102.0 .277 .153
D1S216a 104.8 .384 .350
D1S1728b 109.0 .346 .158
D1S207 113.7 .293 .238
D1S551 113.7 .089 .034
D1S1588 125.5 .093 .097
D1S206b 134.2 .388 .236
D1S1631 136.9 .116 .136
D1S502a 146.5 .423 .395
D1S1675 149.2 .180 .102
D1S252c 150.3 .282 .310
D1S534c 151.9 .260 .285
D1S498a 155.9 .500 .283
D1S1653 164.1 .069 .129
D1S484 169.7 .296 .198
D1S1679 170.8 .166 .087
D1S1677 175.6 .123 .081
D1S2628a 177.9 .640 .311
D1S196b 181.5 .370 .119
D1S218b 191.5 .531 .225
D1S1589b 192.1 .344 .134
D1S518 202.2 .271 .178
D1S238b 202.7 .302 .224
D1S1660 212.4 .213 .182
D1S413c 212.4 .201 .258
D1S1678b 218.5 .355 .118
D1S249c 220.7 .286 .367
IL10-D 222.1 .150 .086
IL10-O 222.1 .229 .139
D1S1663 226.2 .139 .059
D1S229 237.7 .236 .214
D1S549 239.7 .206 .187
D1S213a 242.3 .476 .315
D1S1656b 245.1 .318 .199
D1S3462 247.2 .164 .114
D1S547 267.5 .186 .116
D1S1609 274.5 .086 .114
(continued)
Table 1 (Continued)
CHROMOSOME
AND LOCUS
MAP
LOCATION
(cM)
dc FOR EUROPEAN AMERICAN
VERSUS
African American Hispanic
D1S423b 277.8 .302 .105
Chromosome 2:
D2S319c 7.6 .257 .386
D2S1780b 11.2 .375 .151
D2S281 14.1 .278 .179
D2S162b 20.0 .519 .167
D2S423 22.1 .222 .191
D2S1400b 27.6 .459 .086
D2S1360 38.3 .296 .185
D2S165a 47.4 .351 .264
D2S405 48.0 .169 .108
D2S1788b 55.5 .377 .176
D2S2230 56.2 .298 .167
D2S1356c 64.3 .201 .323
D2S391 70.3 .266 .203
D2S1352 73.6 .252 .164
D2S406 80.2 .161 .111
D2S290a 84.4 .359 .255
D2S1394 90.8 .098 .099
D2S1777 99.4 .290 .093
D2S139a 101.6 .431 .283
D2S1790 104.8 .270 .080
D2S2181a 110.0 .538 .262
IL1RA-O 115.6 .234 .060
D2S160 123.0 .272 .182
IL1A 123.0 .282 .186
D2S121a 123.5 .526 .337
D2S347a 131.5 .405 .251
D2S1328 132.6 .200 .169
D2S114c 142.8 .279 .350
D2S442 147.4 .154 .179
D2S1399 152.0 .187 .150
D2S142 161.3 .228 .212
D2S1353 164.5 .220 .207
D2S1776c 173.0 .147 .262
D2S326a 177.5 .548 .350
D2S1391 186.2 .181 .155
D2S2273a 186.2 .366 .292
D2S117a 194.5 .593 .267
D2S1384 200.4 .138 .177
D2S157b 206.1 .498 .172
D2S2944 210.4 .163 .104
D2S164a 214.7 .442 .250
D2S434 215.8 .107 .076
D2S2197c 222.2 .208 .257
D2S1363 227.0 .217 .146
D2S401a 229.1 .429 .280
D2S396c 232.9 .262 .364
D2S427b 236.7 .460 .097
D2S206b 240.8 .436 .156
D2S338a 250.5 .458 .286
D2S125 260.6 .231 .206
Chromosome 3:
D3S1270 7.0 .271 .194
D3S1297a 8.3 .387 .344
IL5RA 12.3 .184 .129
D3S1560c 19.0 .287 .295
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Table 1 (Continued)
CHROMOSOME
AND LOCUS
MAP
LOCATION
(cM)
dc FOR EUROPEAN AMERICAN
VERSUS
African American Hispanic
D3S1304 22.3 .168 .163
D3S1259a 36.7 .321 .373
D3S2403b 37.2 .418 .140
D3S1293a 44.8 .381 .371
D3S3038 44.8 .112 .103
D3S1266c 52.6 .189 .304
D3S1211a 57.9 .320 .441
D3S2432 57.9 .170 .120
D3S1768 61.5 .202 .086
D3S1298b 62.1 .308
D3S2354b 69.2 .430 .033
AFMb362wb9b 69.5 .333 .071
GAAT12D11 69.5 .182 .020
D3S2409 70.6 .210 .218
D3S3616a 76.5 .381 .293
D3S1766 78.6 .103 .073
D3S1300b 80.3 .373 .200
D3S1285b 91.2 .323 .118
D3S3544 96.7 .247 .174
D3S1284b 102.6 .486 .207
D3S2406 102.6 .103 .185
D3S3671 113.0 .124 .117
D3S2459 119.1 .128 .087
D3S1278a 129.7 .352 .397
D3S2460 134.6 .223 .153
D3S1267a 139.1 .417 .340
D3S3657a 148.2 .305 .767
D3S1238 149.3 .117 .219
D3S1764 152.6 .281 .144
D3S3546 154.5 .225 .193
D3S1744 161.0 .137 .136
D3S196b 161.0 .460 .176
D3S1763 176.5 .134 .111
D3S1282b 180.8 .340 .243
D3S3053 181.9 .105 .091
D3S3715b 190.4 .301 .183
D3S1232a 191.8 .435 .341
D3S1262a 201.1 .301 .289
D3S2398 209.4 .098 .051
D3S1294a 210.1 .423 .275
D3S2418 215.8 .264 .131
D3S1311 224.9 .252 .157
Chromosome 4:
D4S412a 4.7 .348 .280
D4S2366a 12.9 .321 .270
D4S2949a 23.2 .350 .895
D4S403c 25.9 .276 .250
D4S419b 33.4 .323 .218
D4S2639 34.6 .274 .108
D4S2397 42.7 .241 .058
D4S2912b 47.6 .364 .212
D4S2632 54.6 .224 .146
D4S405a 57.0 .308 .318
D4S1627 60.2 .186 .101
D4S428b 64.2 .506 .190
D4S3248 72.5 .058 .171
D4S398a 72.5 .341 .345
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Table 1 (Continued)
CHROMOSOME
AND LOCUS
MAP
LOCATION
(cM)
dc FOR EUROPEAN AMERICAN
VERSUS
African American Hispanic
D4S2367 78.4 .173 .153
D4S3018a 78.4 .352 .277
GCb 79.7 .447 .111
D4S3003b 87.1 .366 .247
D4S3243b 89.2 .323 .064
D4S1534b 95.1 .343 .220
D4S1647 104.9 .128 .080
D4S2623b 114.0 .312 .161
D4S2940 117.1 .145 .232
IL2 125.2 .250 .203
D4S2394 127.0 .281 .136
D4S1579 140.6 .210 .185
D4S1644 143.3 .162 .222
D4S1565 143.8 .268 .100
D4S424c 144.6 .275 .327
D4S1625 146.0 .098 .112
D4S1629b 158.0 .403 .137
D4S413a 158.0 .538 .324
D4S1566c 166.9 .204 .364
D4S2368 167.6 .081 .075
D4S1597b 169.4 .444 .206
D4S2431 176.2 .205 .147
D4S415 181.4 .255 .141
D4S2417 181.9 .104 .100
D4S1535b 195.1 .334 .193
D4S408 195.1 .289 .191
Chromosome 5:
D5S2488 .0 .207 .077
D5S1492 9.4 .098 .068
D5S406a 11.9 .495 .432
D5S2505 14.3 .175 .146
D5S807 19.0 .242 .137
D5S817 22.9 .116 .116
D5S416b 28.8 .568 .168
D5S814 39.5 .105 .086
D5S419a 40.0 .348 .258
D5S1470 45.3 .222 .167
D5S426a 52.0 .355 .277
D5S418a 58.6 .311 .333
D5S1457 59.3 .224 .133
D5S407a 64.7 .384 .333
D5S2500 69.2 .207 .110
D5S647b 74.1 .405 .238
D5S1501 85.3 .244 .232
D5S1716 95.3 .099 .106
D5S428 95.4 .258 .190
D5S644c 104.8 .270 .396
D5S669b 112.5 .315 .222
D5S2501 117.0 .069 .103
D5S421a 122.0 .639 .357
D5S1505 129.8 .093 .129
D5S471b 129.8 .519 .238
D5S2059a 133.7 .365 .342
D5S816 139.3 .109 .134
IL9 139.3 .216 .126
D5S393a 140.7 .352 .286
D5S1480 147.5 .148 .150
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Table 1 (Continued)
CHROMOSOME
AND LOCUS
MAP
LOCATION
(cM)
dc FOR EUROPEAN AMERICAN
VERSUS
African American Hispanic
D5S210b 147.5 .440 .145
D5S436b 147.5 .351 .236
D5S410b 156.5 .593 .214
D5S820 159.8 .207 .231
D5S1955 163.3 .295 .160
D5S2050b 171.1 .300 .169
D5S1471 172.1 .119 .104
D5S1456 174.8 .187 .112
D5S462 178.6 .146 .089
Chromosome 6:
D6S1713a 7.0 .301 .281
SE30a 9.2 .354 .260
D6S309c 14.1 .259 .283
D6S470b 18.2 .311 .190
D6S443c 25.1 .284 .297
D6S1006 26.7 .272 .112
D6S259b 27.8 .422 .175
D6S260 29.9 .297 .239
D6S1588b 38.2 .392 .180
D6S1281 44.4 .077 .069
D6S276b 44.4 .606 .218
TNFB 46.4 .035 .063
D6S1019 53.8 .281 .061
D6S1610a 53.8 .337 .915
D6S426a 60.4 .417 .370
D6S1017 63.3 .298 .083
D6S459c 69.7 .225 .324
D6S1280 73.1 .261 .154
D6S427 73.1 .039 .089
D6S1960 76.6 .083 .119
D6S257 79.9 .282 .233
D6S1031 88.6 .289 .155
D6S286c 89.8 .233 .311
D6S1270 92.6 .206 .058
D6S1570a 99.0 .412 .907
D6S1043c 100.9 .267 .255
D6S434b 109.2 .449 .167
D6S1021 112.2 .236 .089
D6S474 118.6 .062 .090
D6S261c 120.3 .291 .377
D6S1040b 128.9 .323 .137
D6S262b 130.0 .341 .190
D6S976b 135.5 .323 .231
D6S1009 137.7 .157 .190
D6S1003b 144.5 .379 .192
D6S308 144.5 .225 .150
D6S441b 154.1 .327 .214
D6S2436b 154.6 .362 .117
D6S305b 166.4 .373 .152
D6S1277 173.3 .160 .041
D6S264b 179.1 .349 .139
D6S503 184.5 .074 .119
D6S1027b 187.2 .325 .204
D6S446c 189.0 .186 .441
D6S281 190.1 .221 .202
TBPb 190.5 .487 .081
(continued)
Table 1 (Continued)
CHROMOSOME
AND LOCUS
MAP
LOCATION
(cM)
dc FOR EUROPEAN AMERICAN
VERSUS
African American Hispanic
Chromosome 7:
D7S2477c .0 .288 .558
D7S531a 5.3 .373 .314
D7S517a 7.4 .308 .268
D7S2201 10.7 .137 .096
D7S2547 17.2 .196 .213
D7S513 17.7 .296 .180
D7S507a 28.7 .404 .270
D7S493a 34.7 .484 .313
D7S1802 35.3 .236 .194
D7S629a 37.5 .537 .262
D7S1808c 41.7 .210 .277
D7S2416 41.7 .285 .119
D7S526b 49.2 .314 .222
D7S817 50.3 .119 .169
D7S484b 53.5 .346 .238
D7S2846 57.8 .028 .129
D7S2469a 61.5 .335 .589
D7S519b 69.0 .376 .234
D7S1818 69.6 .060 .154
D7S1830 72.8 .129 .072
D7S2429c 76.7 .282 .253
D7S669a 90.4 .315 .268
D7S2212 95.4 .056 .060
D7S2485 98.4 .239 .182
D7S820 98.4 .161 .192
D7S657b 104.9 .767 .223
D7S821 109.1 .247 .172
D7S662a 111.8 .370 .282
D7S1799 113.9 .164 .147
D7S692 121.4 .273 .147
D7S2847b 125.2 .338 .146
D7S650a 126.8 .489 .449
D7S530c 134.6 .287 .289
D7S640a 137.8 .595 .452
D7S684c 147.2 .254 .256
D7S1824 149.9 .182 .161
D7S2195b 150.4 .312 .156
D7S661a 155.1 .324 .310
TCRB-6.1 155.6 .105 .099
TCRB-6.4 155.6 .296 .119
TCRB-6.7 155.6 .197 .138
TCRB-Eb 155.6 .423 .170
TCRB-Fb 155.6 .433 .119
D7S1805 161.2 .119 .130
D7S505 161.2 .231 .204
D7S1826 162.3 .071 .096
D7S3058 173.7 .122 .056
D7S550b 178.4 .493 .240
D7S2423a 182.0 .339 .890
D7S559 182.0 .207 .176
Chromosome 8:
D8S504 .0 .228 .115
D8S262b 4.3 .353 .118
D8S277a 8.3 .337 .333
D8S550b 21.3 .351 .232
(continued)
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D8S1130 22.4 .166 .113
D8S1106c 26.4 .153 .336
D8S1827a 30.5 .399 .792
D8S258b 41.6 .356 .115
D8S136a 44.0 .419 .275
D8S1739 48.8 .219 .168
D8S1477 60.3 .155 .240
D8S283a 60.9 .350 .300
D8S505c 60.9 .181 .306
D8S1110 67.3 .185 .139
D8S285a 71.0 .346 .348
D8S1113 77.9 .202 .112
D8S260c 79.4 .249 .308
D8S1136 82.3 .066 .147
D8S1775b 87.5 .339 .132
D8S279a 91.5 .372 .387
D8S1697a 98.9 .471 .300
D8S1119b 101.0 .376 .150
GAAT1A4 110.2 .142 .080
D8S257 111.7 .153 .135
D8S1784b 118.2 .398 .215
D8S1132 119.2 .254 .143
D8S592 125.3 .205 .085
D8S514a 130.0 .439 .291
D8S508 137.9 .241 .153
D8S1128 139.5 .291 .202
D8S284b 143.8 .454 .198
D8S1100 154.0 .271 .131
D8S272a 154.0 .500 .257
D8S1741b 162.9 .472 .210
D8S373b 164.5 .336 .084
Chromosome 9:
D9S1858 .0 .252 .113
D9S288c 9.8 .193 .290
D9S2169 14.2 .282 .085
D9S286 18.1 .279 .230
D9S269 24.1 .202 .218
D9S156a 30.6 .344 .405
IFNA 33.3 .115 .063
D9S1870a 37.6 .369 .283
D9S171a 42.7 .341 .305
D9S161b 51.8 .474 .238
D9S741 52.7 .284 .175
D9S319 54.5 .161 .068
D9S273 65.8 .258 .186
D9S301c 66.3 .163 .311
D9S175a 70.3 .602 .400
D9S1122 75.9 .061 .148
D9S922 80.3 .178 .144
D9S167a 83.4 .302 .300
D9S257b 91.9 .317 .243
D9S1781 99.4 .253 .235
D9S910 104.5 .223 .151
D9S176c 105.0 .239 .254
D9S938c 110.9 .229 .257
D9S1675a 120.0 .320 .280
D9S930 120.0 .094 .138
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D9S154a 125.6 .502 .355
D9S934 128.0 .080 .102
D9S266a 136.5 .451 .562
D9S164 147.9 .196 .165
D9S1826c 159.6 .246 .303
Chromosome 10:
D10S249a 2.1 .397 .341
D10S602 4.3 .209 .154
D10S1435 6.2 .115 .105
D10S1713 13.5 .232 .178
D10S189 19.0 .286 .121
D10S1412 28.3 .184 .215
D10S547b 29.2 .323 .157
D10S2325 32.8 .245 .180
D10S1423 46.5 .104 .112
D10S1662 48.4 .178 .167
D10S197b 52.1 .381 .167
D10S1426 59.0 .100 .083
D10S208b 60.6 .323 .220
D10S1220 70.2 .162 .066
D10S1225 80.8 .256 .110
D10S1652b 80.8 .342 .235
D10S1670a 86.2 .425 .365
D10S1432 93.9 .156 .085
D10S1699 97.3 .182 .107
D10S2327b 100.9 .398 .065
D10S1786a 103.4 .482 .636
D10S1739 110.0 .113 .200
D10S583a 115.3 .402 .255
D10S677 117.4 .229 .142
D10S192b 124.3 .364 .224
D10S1239 125.9 .146 .081
D10S1682b 130.9 .352 .126
D10S1237 134.7 .292 .101
D10S1230b 142.8 .352 .168
D10S587 147.6 .177 .158
D10S1213 148.2 .243 .229
D10S1223 152.9 .287 .185
D10S1703a 155.7 .421 .310
D10S1651c 168.8 .242 .279
D10S212 170.9 .105 .030
D10S555c 170.9 .189 .272
D10S169 173.1 .275 .108
Chromosome 11:
D11S1984 2.1 .189 .168
D11S2362 8.9 .231 .129
D11S1999 17.2 .128 .176
D11S1981 21.5 .188 .116
D11S902a 21.5 .409 .290
D11S915a 30.9 .318 .405
D11S904b 33.6 .319 .189
D11S1776 40.1 .237 .126
D11S935a 45.9 .564 .261
D11S905b 52.0 .494 .232
D11S1313a 58.4 .376 .286
D11S1985 58.4 .219 .190
D11S4155 67.5 .291 .139
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D11S987 67.5 .249 .241
D11S2371 76.1 .172 .103
D11S4207b 76.1 .301
D11S937a 80.0 .511 .380
D11S1396 85.5 .254 .088
D11S2002 85.5 .205 .110
D11S4197a 87.9 .313 .583
D11S4134 96.9 .250 .185
D11S2000b 100.6 .357 .199
D11S1893a 105.2 .421 .317
D11S1986c 105.7 .238 .250
D11S1998 113.1 .171 .205
D11S925a 118.5 .453 .306
D11S4464 123.0 .054 .128
D11S934c 126.2 .268 .286
D11S1351a 131.3 .307 .396
D11S912 131.3 .297 .221
D11S968c 147.8 .105 .310
Chromosome 12:
D12S352a .0 .479 .449
D12S94c 1.2 .239 .257
D12S372 6.4 .092 .069
D12S1626c 7.1 .243 .316
D12S1673 12.6 .167 .138
D12S99c 12.6 .271 .275
CD4b 16.4 .390 .163
D12S358b 26.2 .313 .218
D12S391 26.2 .257 .185
D12S364a 30.6 .364 .370
D12S373 36.1 .052 .068
D12S1042 48.7 .280 .163
D12S1640 48.7 .189 .157
D12S1663 56.4 .220 .141
D12S85b 61.3 .332 .109
D12S1618 68.2 .199 .222
D12S398 68.2 .181 .197
D12S83a 75.2 .448 .356
D12S1294 76.1 .224 .177
D12S375 80.5 .133 .066
D12S1052 83.2 .056 .097
D12S92b 83.2 .315 .190
D12S1064 95.0 .123 .236
D12S95b 96.1 .331 .164
D12S1657b 102.0 .340 .107
D12S1300 105.0 .127 .120
PAH 109.5 .187 .169
D12S78a 111.9 .320 .318
D12S2070 125.3 .178 .232
D12S79a 125.3 .465 .305
D12S366a 133.3 .446 .265
D12S395 136.8 .111 .108
D12S342a 144.8 .387 .315
D12S2078 148.0 .161 .112
D12S1679 153.2 .162
D12S1045b 160.7 .356 .123
D12S97b 160.7 .375 .240
D12S1638 168.8 .234 .082
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Chromosome 13:
D13S175c 6.0 .209 .278
D13S787 8.9 .159 .172
D13S221c 12.9 .279 .285
D13S1254c 14.5 .283 .300
D13S260a 23.7 .517 .369
D13S1493 25.8 .137 .224
D13S219b 28.9 .477 .179
D13S894 33.5 .102 .119
D13S263a 38.3 .360 .311
D13S153a 45.6 .354 .355
D13S788b 45.6 .345 .231
D13S1309c 50.5 .295 .860
D13S800 55.3 .081 .099
D13S162 58.5 .284 .211
D13S170b 63.9 .371 .245
D13S317 63.9 .215 .186
D13S265a 68.7 .397 .256
D13S793 74.9 .271 .046
D13S154a 75.2 .308 .277
D13S779 82.9 .212 .224
D13S158b 84.9 .402 .190
D13S173 93.5 .119 .136
D13S796b 93.5 .455 .110
D13S1315a 102.7 .323 .267
D13S285b 110.6 .307 .165
Chromosome 14:
D14S72b 9.4 .386 .175
D14S742 12.5 .078 .037
D14S283 13.9 .296 .226
D14S990c 14.6 .263 .292
D14S1041 23.2 .268 .141
D14S1280 25.9 .171 .091
D14S80c 26.6 .276 .311
D14S597 28.0 .240 .148
D14S297 31.8 .191 .111
D14S49 36.8 .222 .223
D14S1049b 40.9 .316 .197
D14S306 44.1 .050 .123
D14S288a 47.5 .369 .266
D14S587 55.8 .259 .202
D14S274a 63.3 .514 .251
D14S592b 66.8 .301 .135
D14S63a 69.2 .374 .301
D14S588b 75.6 .345 .106
D14S258a 76.3 .394 .339
D14S1036b 84.7 .318 .228
D14S53 86.3 .200 .104
D14S74b 87.4 .302 .143
D14S606 91.6 .138 .115
D14S610 95.9 .110 .082
D14S68a 95.9 .533 .473
D14S1044b 99.9 .487 .227
D14S617 105.5 .266 .093
D14S749 108.2 .101 .173
D14S81a 108.2 .408 .265
D14S51b 115.6 .359 .235
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D14S611 115.9 .255 .155
D14S78 125.9 .217 .108
D14S260b 134.3 .448 .141
D14S1007a 138.2 .307 .317
Chromosome 15:
D15S128b 6.1 .381 .232
D15S1002a 14.6 .494 .275
D15S165b 20.2 .327 .114
ACTC 31.5 .204 .130
D15S659 43.5 .187 .129
D15S126 45.6 .176 .239
D15S978a 45.6 .328 .376
D15S117a 51.2 .352 .263
D15S643 52.3 .216 .162
D15S1036b 57.4 .459 .206
D15S153b 62.4 .438 .178
D15S131a 71.3 .311 .438
D15S973b 73.5 .344 .134
D15S205c 78.9 .291 .333
D15S152 80.0 .229 .161
D15S127b 86.8 .399 .173
D15S652 90.0 .137 .185
D15S130b 100.6 .384 .244
D15S816 100.6 .120 .095
D15S657 104.9 .157 .076
D15S120a 112.6 .487 .297
Chromosome 16:
D16S3024 7.1 .258 .227
D16S2622b 8.2 .445 .201
D16S423a 10.4 .401 .343
D16S748b 22.7 .339 .218
D16S3075c 23.3 .276 .266
D16S2619 28.3 .058 .058
D16S405 28.3 .289 .201
D16S3017a 32.1 .375 .252
D16S3046b 40.7 .316 .201
D16S403 43.9 .204 .202
D16S420a 44.5 .356 .491
D16S401a 46.9 .521 .282
D16S769 50.6 .036 .070
D16S753 57.8 .203 .078
D16S409b 58.5 .326 .249
D16S771 70.7 .141 .145
D16S3253b 71.8 .337 .171
D16S503a 83.6 .368 .259
D16S2624 87.6 .156 .093
D16S515a 92.1 .460 .297
D16S518b 95.1 .412 .236
D16S511a 110.4 .417 .330
D16S422a 111.1 .327 .352
GATA86C08 120.6 .185 .168
D16S3023 132.6 .174 .191
Chromosome 17:
D17S1308 .6 .283 .081
D17S849a .6 .334 .264
D17S1298 10.7 .258 .065
D17S796a 14.7 .470 .293
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D17S938a 14.7 .513 .346
D17S1852a 22.2 .380 .334
D17S974 22.2 .236 .131
D17S1303 23.6 .159 .154
D17S969 27.8 .164 .110
D17S799a 32.0 .445 .364
D17S921b 36.1 .377 .077
D17S122 41.1 .190 .148
D17S959b 48.1 .362 .219
D17S1294 50.7 .219 .162
D17S798b 53.4 .329 .193
D17S791a 64.2 .354 .419
D17S809 74.5 .253 .092
D17S787a 75.0 .414 .291
D17S1290 82.0 .244 .204
D17S924c 82.0 .187 .328
D17S789b 89.3 .333 .208
D17S2059 93.3 .101 .073
D17S1301 100.0 .202 .042
D17S802a 106.8 .342 .411
D17S1822a 116.9 .426 .300
D17S784b 116.9 .322 .148
D17S928 126.5 .241 .073
Chromosome 18:
D18S59 .0 .255 .123
D18S481b 6.9 .455 .208
D18S976a 12.8 .396 .270
D18S843 28.1 .114 .129
D18S464a 31.2 .390 .301
D18S877 54.4 .246 .110
D18S1135b 61.7 .487 .242
D18S57a 62.8 .313 .282
D18S535 64.5 .136 .123
D18S474b 71.3 .313 .211
D18S851 73.8 .193 .110
D18S69b 77.4 .303 .179
D18S858 80.4 .154 .122
D18S64b 84.8 .388 .084
D18S68a 96.5 .402 .329
GATA175B10c 96.5 .264 .270
D18S61a 105.0 .423 .287
ATA82B02 106.8 .251 .119
D18S1161a 114.3 .313 .338
D18S844 116.4 .149 .134
Chromosome 19:
D19S591 9.8 .217 .112
D19S216 20.0 .270 .080
D19S413b 32.4 .374 .150
D19S586 32.9 .077 .113
D19S221b 36.2 .341 .218
ERBAL2 37.8 .211 .176
D19S226a 42.3 .443 .355
D19S714 43.1 .101 .091
D19S1037 47.7 .093 .110
D19S433 51.9 .280 .117
D19S220b 62.0 .403 .204
D19S198 65.8 .228 .088
(continued)
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D19S412b 70.1 .421 .174
D19S246 78.1 .167 .154
D19S589 87.7 .111 .067
D19S887b 100.0 .314 .131
D19S254 100.6 .247 .113
Chromosome 20:
D20S117b 2.8 .490 .197
D20S473 9.5 .257 .142
D20S116b 11.2 .371 .174
D20S115b 21.2 .376 .080
D20S189b 30.6 .336 .154
D20S604 32.9 .148 .111
D20S112b 39.3 .339 .229
D20S470 39.3 .240 .178
D20S477 50.1 .161 .104
D20S107c 55.7 .191 .307
D20S119b 61.8 .487 .105
D20S481 62.3 .180 .141
D20S196a 75.0 .576 .341
D20S120a 83.5 .403 .252
D20S171 95.7 .278 .117
Chromosome 21:
D21S1432 3.0 .125 .087
D21S1414c 9.7 .270 .376
D21S1437b 13.1 .356 .134
D21S1918b 16.2 .319 .237
D21S214a 16.9 .436 .286
D21S1270b 27.4 .405 .148
D21S1440b 36.8 .354 .168
D21S167b 38.7 .391
D21S156b 42.6 .338 .188
D21S266 45.9 .289 .132
D21S171c 53.9 .224 .286
D21S1446b 57.8 .334 .144
Chromosome 22:
D22S420b 4.1 .315 .104
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D22S1174 19.3 .186 .114
D22S264b 21.1 .485 .152
D22S315a 21.5 .453 .282
D22S1176 29.7 .211 .137
D22S280c 31.3 .233 .250
D22S685 32.4 .205 .178
D22S283a 38.6 .425 .333
IL-2RBb 42.8 .319 .130
IL2RBAb 42.8 .304 .156
D22S445b 45.8 .358 .096
D22S294c 51.4 .267 .361
D22S274a 51.5 .410 .327
Chromosome X:
DXS987c 22.0 .286 .400
DXS1202a 38.4 .607 .469
DXS1214b 45.0 .378 .225
DXS1068b 52.6 .313
DXS993a 62.5 .303 .395
PFCb 68.3 .529 .108
DXS1055 72.4 .192 .179
DXS990a 99.7 .613 .357
DXS1106b 111.8 .362 .087
DXS1001a 130.4 .371 .300
DXS1047a 143.2 .402 .414
DXS1227 155.9 .260 .200
NOTE.—Map positions were estimated from the Marshfield
map, with some loci included by interpolation from radiation
hybrid data. Primer sequences and additional data on all six dc
and LLAR comparisons, along with I*(2) for African Americans
and Hispanics, are available at the Laboratory of Genomic Di-
versity Web site.
a Markers which have dc values that meet the two criteria above
for African Americans and Hispanics.
b African American MALD markers with dc  .30 when com-
pared to European Americans.
c Hispanic MALD markers with dc  .25 when compared to
European Americans.
gence is apparent. In the comparison of African Amer-
icans versus Europeans, 44% of STR loci show ,d 1 .3c
and 74% of loci show . For the Hispanic-Euro-d 1 .2c
pean comparison, 17% of loci have , and 45%d 1 .3c
have . These differences are critical, insofar as thed 1 .2c
size of d and dc are the principal determinants of linkage-
disequilibrium detection in admixed populations (Chak-
raborty and Weiss 1988; Chakraborty et al. 1991; Ste-
phens et al. 1994, 1999). The operative dc for Hispanics
and African Americans is almost certainly underesti-
mated here, since our comparison utilized admixed pop-
ulations and not the actual parent population—native
Africans, in the case of African Americans. To illustrate
this underestimation, consider the comparison of Af-
rican Americans versus Asians (fig. 4A, B), which shows
the greatest dc, since these populations do not share any
recent gene flow. This comparison shows 80% of STR
loci with and 95% of the loci with . Thesed 1 .3 d 1 .2c c
values are a plausible surrogate estimator of similar
mean distances between native African and European
population structure. However, it is not expected that
the same loci with high dc in the Asian versus African
American comparison would be the same as those with
high dc in other comparisons. This discordance is illus-
trated in figure 2C, where the correlation between STR
dc values in comparisons of different ethnic groups is
low ( ), considering that both comparisons are2r p .25
with the same European American reference group.
Discussion
The development of allele frequency data for MALD
mapping is critical to the advancement of the method-
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ology for gene mapping studies. The theoretical basis of
MALD mapping is now well established (Chakraborty
and Weiss 1988; Chakraborty et al. 1991; Briscoe et al.
1994; Stephens et al. 1994; McKeigue 1997, 1998; Ste-
phens et al. 1999; Zheng and Elston 1999). Empirical
studies have also found MALD over large distances of
as much as 30 cM around the FY gene in African Amer-
icans, and strong linkage disequilibrium was found with
STRs in an 8-cM core around the FY gene (Parra et al.
1998; Hamblin and Di Rienzo 2000; Lautenberger et al.
2000; Wilson and Goldstein 2000). There is ample ev-
idence that ongoing and differential levels of admixture
across populations must be taken into account in any
disease gene identification efforts (Parra et al. 2001; Pfaff
et al. 2001). Others have attempted to identify markers
appropriate for MALD (Dean et al. 1994; Collins et al.
2000), but the present study represents the largest to
date. Taken together, these results suggest that the ∼10-
cM map of markers presented here makes a good foun-
dation for MALD-based gene mapping in the African
American and Hispanic populations.
The present study examines 744 markers, to identify
those that are best able to differentiate between found-
ing populations; such markers would be appropriate for
MALD analysis in Hispanics or African Americans.
Only weak correlations were found between dc, LLAR,
or I*(2) in the European American versus AfricanAmer-
ican and the European American versus Hispanic com-
parisons (fig. 4C and analyses not shown), so that the
two groups of markers for MALD are nearly randomly
overlapping. Those markers ( ) with a dc of.30np 315
have an average spacing of 11 cM in African Americans,
and those with dc.25 ( markers) in Hispanicsnp 214
have an average spacing of 16 cM; these two groups
share 153 markers in common (indicated in table 1).
There is some concern that these STR-based markers
will be supplanted by SNP; however, several factors
work to the advantage of STRs. They are relatively easy
to assay via direct PCR amplification and separation on
commercial sequencers. In MALD-TDT applications,
the diversity of alleles seen at STRs will make TDT trios
more generally informative than biallelic SNP markers
(Spielman et al. 1993; McKeigue 1997, 1998). Those
multiallelic advantages of STRs could be counterbal-
anced by multiallelic haplotypes based on SNPs. How-
ever, STR technology is in hand and works quite well,
whereas SNP genotyping technology is currently in a
state of flux (Kristensen et al. 2001).
We have examined genomewide marker frequency
data to explore the possibility of autocorrelation of
marker dc values in African-Americans and Hispanics.
This analysis was undertaken because the existence of
positive autocorrelation could influence both historical
inferences and the search for genetic regions that con-
tribute to ethnic differences in phenotype distribution.
Positive autocorrelation between closely spaced pairs of
markers would have occurred if nearby markers tended
to have similar dc values, yet neighbors are as similar
as randomly selected loci in dc differences (fig. 3).
Biologically speaking, appropriate MALD markers
depend on the disease model. In the case of African
Americans, at least 30 diseases with a likely hereditary
component have a higher prevalence in this minority
group than in European Americans (Williams 1999).
Thus, although searching for a European disease allele
in African Americans has, theoretically, the most power,
the empirical approach is to search for an African one.
Markers most appropriate for this case have alleles with
high frequencies in African Americans that are absent
in European Americans.
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